title: The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
abstract: GH has acute stimulatory effects on amino acid transport and protein synthesis in a variety of tissues, but it has not been established whether these effects are expressions of the growth-promoting property of GH or of its separate insulin-like action. The 20,000-dalton structural variant of human GH (20K hGH) has been shown to have a high ratio of growth-promoting to insulin-like activity compared to native hGH (22K hGH), suggesting that it could be used as a tool to address the above question. Therefore, experiments were conducted to compare the relative abilities of native 22K hGH and 20K hGH, when added in vitro, to stimulate amino acid transport and protein synthesis in the isolated diaphragm of the female hypophysectomized rat. Paired intact hemidiaphragms were preincubated for 1 h in the absence or presence of various concentrations of 22K or 20K hGH. Then, 3-O-[14C]methylglucose was added to the medium to measure sugar transport as a test of insulin-like activity, and either alpha-[3H]aminoisobutyric acid acid or [3H] phenylalanine was also added to measure amino acid transport or protein synthesis, respectively, during a final hour of incubation. When the responses to the various concentrations of 22K and 20K were compared, 20K hGH was only about 20% as effective as 22K in stimulating 3-O-methylglucose transport, reflecting its markedly attenuated insulin-like activity on the diaphragm. Similarly, 20K hGH was only 20% as effective as 22K hGH in stimulating alpha-aminoisobutyric acid transport and phenylalanine incorporation into protein in the same muscles. Therefore, these findings support the idea that the rapid stimulatory effects of GH on amino acid transport and protein synthesis are expressions of the insulin-like action of GH and are not components of the response of target cells to its growth-promoting action.
authors.affiliation: Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622.
authors.forename: C M
authors.initials: CM
authors.lastname: Cameron
authors.forename: J L
authors.initials: JL
authors.lastname: Kostyo
authors.forename: N A
authors.initials: NA
authors.lastname: Adamafio
authors.forename: P
authors.initials: P
authors.lastname: Brostedt
authors.forename: P
authors.initials: P
authors.lastname: Roos
authors.forename: A
authors.initials: A
authors.lastname: Skottner
authors.forename: A
authors.initials: A
authors.lastname: Forsman
authors.forename: L
authors.initials: L
authors.lastname: Fryklund
authors.forename: B
authors.initials: B
authors.lastname: Skoog
mesh_terms: D019325:3-O-Methylglucose; D000596:Amino Acids / Q000378:metabolism*; D000621:Aminoisobutyric Acids / Q000378:metabolism; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D005260:Female; D013006:Growth Hormone / Q000494:pharmacology*; D019382:Human Growth Hormone; D007016:Hypophysectomy; D007328:Insulin / Q000502:physiology*; D008757:Methylglucosides / Q000378:metabolism; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D010446:Peptide Fragments / Q000494:pharmacology; D014176:Protein Biosynthesis; D051381:Rats
chemical_list: D000596:Amino Acids; D000621:Aminoisobutyric Acids; D007328:Insulin; D008757:Methylglucosides; D010446:Peptide Fragments; C039519:somatotropin 20K; D019382:Human Growth Hormone; D019325:3-O-Methylglucose; C100049:2-aminoisobutyric acid; D013006:Growth Hormone